These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 1829359)
1. Contribution of cyclosporin metabolites to immunosuppression in liver-transplanted patients with severe graft dysfunction. Schlitt HJ; Christians U; Bleck J; Kohlhaw K; Ringe B; Bunzendahl H; Sewing KF; Wonigeit K; Pichlmayr R Transpl Int; 1991 Apr; 4(1):38-44. PubMed ID: 1829359 [TBL] [Abstract][Full Text] [Related]
2. Cyclosporin A metabolites suppress T-cell proliferation by concanavalin A and in a mixed lymphocyte reaction. Abecassis M; Wong PY; Mason N; Cheung F; Mee AV; Cole EH; Langer B; Cohen Z; Levy GA Can J Surg; 1988 May; 31(3):145-50. PubMed ID: 2966666 [TBL] [Abstract][Full Text] [Related]
3. The synergistic immunosuppressive potential of cyclosporin metabolite combinations. Radeke HH; Christians U; Sewing KF; Resch K Int J Immunopharmacol; 1992 May; 14(4):595-604. PubMed ID: 1521927 [TBL] [Abstract][Full Text] [Related]
4. Cyclosporin G and metabolite binding to cyclophilin and a 50-kDa binding protein related to in vitro immunosuppression. Donnelly JG; Chen Y; Yatscoff RW; Copeland KR; Palaszynski EW; Soldin SJ Clin Chem; 1993 Jan; 39(1):122-5. PubMed ID: 8419033 [TBL] [Abstract][Full Text] [Related]
5. The determination of metabolite M17 and its meaning for immunosuppressive cyclosporin therapy. Khoschsorur G; Auer T; Lanzer G; Petritsch P; Holzer H; Tscheliessnigg KH Angiology; 1998 Apr; 49(4):307-14. PubMed ID: 9555934 [TBL] [Abstract][Full Text] [Related]
6. Sensitivity of activated human lymphocytes to cyclosporine and its metabolites. Zeevi A; Venkataramanan R; Burckart G; Wang CP; Murase N; Van Thiel DH; Starzl TE; Makowka L; Duquesnoy RJ Hum Immunol; 1988 Feb; 21(2):143-53. PubMed ID: 2966788 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the effects of cyclosporin G (OG37-325), cyclosporin A, and their metabolites on the release of endothelin and prostacyclin from primary renal and aortic endothelial cell lines. Langman LJ; Yatscoff RW Ther Drug Monit; 1994 Oct; 16(5):450-7. PubMed ID: 7846742 [TBL] [Abstract][Full Text] [Related]
8. [Measuring cyclosporin in immunosuppressive treatment following liver and heart transplantation]. Hamilton G; Roth E; Mühlbacher F; Funovics J; Piza F; Schindler J; Woloszcuk W; Havel M; Laczkovics A Wien Klin Wochenschr; 1986 Dec; 98(24):820-4. PubMed ID: 3548080 [TBL] [Abstract][Full Text] [Related]
9. Involvement of cyclosporine metabolites in therapeutic monitoring and immunosuppression. Rosano TG; Freed BM; Pell MA; Dybas MT; Lempert N Transplant Proc; 1987 Feb; 19(1 Pt 2):1699-703. PubMed ID: 2950633 [No Abstract] [Full Text] [Related]
10. Comparison of cyclosporin A and G with and without azathioprine regarding immunosuppressive efficacy, toxicity, and pharmacokinetics in Lewis rats. Hagberg RC; Hoyt EG; Billingham ME; Sibley RK; Starnes VA; Baldwin JC J Heart Transplant; 1988; 7(5):359-69. PubMed ID: 3058906 [TBL] [Abstract][Full Text] [Related]
11. Immunosuppressive activity of cyclosporine metabolites compared and characterized by mass spectroscopy and nuclear magnetic resonance. Copeland KR; Yatscoff RW; McKenna RM Clin Chem; 1990 Feb; 36(2):225-9. PubMed ID: 2137384 [TBL] [Abstract][Full Text] [Related]
13. Assessment of immunosuppression by serum inhibition of alloreaction and measurement of cyclosporin A (CyA) serum levels in kidney graft recipients under CyA. Chabannes D; Vernillet L; Cantarovich D; Humbert H; Vie H; Soulillou JP Transpl Int; 1990 Dec; 3(4):189-94. PubMed ID: 2076168 [TBL] [Abstract][Full Text] [Related]
14. Orthotopic liver transplantation. Various immunosuppressive regimens to improve survival. Toledo-Pereyra LH; Bandlien KO; MacKenzie GH; Gordon DA Am Surg; 1984 May; 50(5):258-63. PubMed ID: 6372562 [TBL] [Abstract][Full Text] [Related]
15. Measurement of AM19 and other cyclosporine metabolites in the blood of liver transplant patients with stable liver function. Liu WT; Levy GA; Wong PY Ther Drug Monit; 1995 Oct; 17(5):479-86. PubMed ID: 8585111 [TBL] [Abstract][Full Text] [Related]
16. In vitro immunosuppressive activity, isolation from pig liver microsomes and identification by electrospray ms-ms of a new FK-506 C19-C20 epoxide metabolite. Lhoëst G; Dieden R; Verbeeck RK; Maton N; Ingendoh A; Latinne D J Pharmacol Exp Ther; 1998 Mar; 284(3):1074-81. PubMed ID: 9495869 [TBL] [Abstract][Full Text] [Related]
18. Slow accumulation of cyclosporin metabolites as measured by specific and nonspecific cyclosporin RIA. Keller F; Kunzendorf U; Walz G; Schwarz A; Offermann G Int J Clin Pharmacol Ther Toxicol; 1990 Apr; 28(4):167-75. PubMed ID: 2338370 [TBL] [Abstract][Full Text] [Related]
19. Toxic effects on renal cells in culture--a comparison of cyclosporin A and its metabolites. Cole E; Cheung F; Wong PY; Fung LS; Skorecki K; Levy GA Transplant Proc; 1989 Feb; 21(1 Pt 1):943-5. PubMed ID: 2468230 [No Abstract] [Full Text] [Related]
20. Immunosuppressive metabolites of cyclosporine in the blood of renal allograft recipients. Rosano TG; Freed BM; Cerilli J; Lempert N Transplantation; 1986 Sep; 42(3):262-7. PubMed ID: 2944258 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]